1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > COLORECTAL CANCER DRUGS INDUSTRY AND MARKET: THERAPIES, R&D AND FORECASTS 2015-2025

COLORECTAL CANCER DRUGS INDUSTRY AND MARKET: THERAPIES, R&D AND FORECASTS 2015-2025

  • November 2015
  • -
  • Visiongain
  • -
  • 114 pages

Summary

Table of Contents

Please note: The license is valid for 12 months from the date the report is sent.


Do you want to assess the future of colorectal cancer medicines? Visiongain’s new report gives you revenue predictions for that industry from 2015, helping you stay ahead in knowledge and benefit your influence.

Our study shows you results, R&D trends, opportunities, interviews and revenue forecasts.

In that analysis you see predicted revenues to 2025 at overall world market, geographical and product level. You assess emerging trends, technologies and branded therapies. Explore the future of colorectal cancer drugs and their producers.

With our study, benefit your research, decisions, presentations and influence. Please read on now to discover how our new analysis can help your work.


Main ways Colorectal Cancer Drugs Industry and Market: Therapies, R&D and Forecasts 2015-2025 helps you
In these six main ways, visiongain’s new analysis gives knowledge to make your work easier and faster, also benefiting your decisions and authority:

- Revenue forecasting of the overall world market and 5 geographical submarkets – assess outlooks for development, production, marketing and sales, seeing what is possible

- Nine leading drugs’ revenues to 2025 – find sales potentials for top brands, seeing how they can compete and succeed


- Profiles of leading companies – assess participants’ results, portfolios, capabilities, deals and outlooks


- R&D in colorectal cancer treatment – explore progress in research and development, finding technological, medical and commercial possibilities


- Interviews with two other authorities – discover opinions to help you stay ahead in knowledge, finding what companies say and do


- Analysis of what stimulates and restrains that pharma industry – assess challenges and opportunities, helping you gain advantages and succeed.



What forces stimulate the market for colorectal cancer treating medicines?

In 2015 there exist at least 158 agents in clinical development for colorectal cancer. A large number of those products are in phase II development. Our report helps you understand opportunities in that field and how to use them.



As ageing populations increase, the incidence of cancer rises, leading to rising spending on cancer-treating medicines. That trend will continue. Are you ready for those commercial opportunities? Let our study guide you, showing what is possible.



Gain data found nowhere else, benefiting your influence on those anticancer medicines
Visiongain’s study examines the colorectal cancer drugs market, using independent primary and secondary research. Gain discussions and data you find nowhere else.



In our new report you gain 35 charts, 29 tables and two research interviews to help you stay ahead in knowledge.



Forecasts for nine leading drugs – discover sales potentials
Our new investigation gives you revenue forecasts to 2025 for nine leading products for treating colorectal cancer:

- Avastin (Roche)
- Erbitux (BMS/Merck Serono)
- Xeloda (Roche)
- Vectibix (Amgen)
- Stivarga (Bayer)
- Eloxatin (Sanofi)
- TS-1 (Taiho Pharmaceuticals)
- Zaltrap (Sanofi)
- Cyramza (Eli Lilly).

In our work you also see profiles of leading companies and discussions of drugs in development. Our analysis explains activities and prospects of organisations developing, producing and marketing those therapies.

See what the future holds for products treating that disease. Our report explains, from 2015, pharma companies’ commercial prospects. Explore what the future holds.

Geographical markets – where lie the best sales and growth potentials?
Our survey also shows forecasts to 2025 for these five regions, showing overall colorectal cancer drug revenues:

- United States

- European Union

- Japan

- APAC

- Rest of the world.



That way you discover where revenue growth will occur in established pharma markets and in developing countries. Discover where the best prospects for sales and business expansion lie.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • January 2017
  • by GlobalData

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected ...

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Other. 2017-2020

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Other. 2017-2020

  • $ 5495
  • Industry report
  • March 2017
  • by Howe Sound Research

Circulating Tumor Cell, Cell Free DNA and Exosome/Microvesicle Cancer Diagnostics by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and ...

Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides

Liquid Biopsy Markets by Lung, Breast, Colorectal, Prostate and Other. 2017-2020 Including Screening Market Potential Size with Executive and Consultant Guides

  • $ 5495
  • Industry report
  • March 2017
  • by Howe Sound Research

“Blood Tests replace Surgical Biopsies. Single screening test for all cancers announced .....” The Diagnostic, Monitoring and Screening Test opportunities are explored. A revolution in cancer diagnostics ...


Download Unlimited Documents from Trusted Public Sources

Endocrine Disease Statistics in the US

  • April 2017
    122 pages
  • Endocrine Disea...  

    Diabetes Monito...  

    Hospital  

  • United States  

    North America  

View report >

Cancer Statistics - Forecast

  • April 2017
    10 pages
  • Cancer  

  • Europe  

    United Kingdom  

    United States  

View report >

Cancer Statistics in the US

  • April 2017
    24 pages
  • Cancer  

    Healthcare Fina...  

  • United States  

View report >

Related Market Segments :

Colorectal Cancer

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.